How the FDA could boost gender-affirming care
Briefly

For years, transgender patients have received hormone therapies 'off label' - a common medical practice in which doctors prescribe treatments for a use the agency hasn't approved.
Research has shown that receiving gender-affirming care is associated with better mental health, including lower risk of depression and self-harm or suicidal thoughts, among transgender youth.
Read at Axios
[
|
]